Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-04
DOI
10.3389/fonc.2021.705331
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progesterone and vitamin D downregulate the activation of the NLRP1/NLRP3 inflammasomes and TLR4-MyD88-NF-κB pathway in monocytes from pregnant women with preeclampsia
- (2021) Mariana Leticia Matias et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma
- (2021) Dafei Chai et al. Translational Oncology
- Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8
- (2021) Anirban Roychowdhury et al. GENE
- BRCA1 Deficiency Impairs Mitophagy and Promotes Inflammasome Activation and Mammary Tumor Metastasis
- (2020) Qiang Chen et al. Advanced Science
- Globular adiponectin antagonizes leptin-induced growth of cancer cells by modulating inflammasomes activation: Critical role of HO-1 signaling
- (2020) Pawan Kumar Raut et al. BIOCHEMICAL PHARMACOLOGY
- Role of inflammation in the development of colorectal cancer
- (2020) Sridhar Muthusami et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Inflammasome Deletion Promotes Anti-tumor NK Cell Function in an IL-1/IL-18 Independent Way in Murine Invasive Breast Cancer
- (2020) Baptiste Guey et al. Frontiers in Oncology
- NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
- (2020) Margherita Sonnessa et al. Frontiers in Oncology
- NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
- (2020) Fei Lu et al. CANCER LETTERS
- Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells
- (2019) Junhui Yu et al. Cell Death & Disease
- Growth of breast cancer cells by leptin is mediated via activation of the inflammasome: Critical roles of estrogen receptor signaling and reactive oxygen species production
- (2019) Pawan Kumar Raut et al. BIOCHEMICAL PHARMACOLOGY
- The NF-KB pathway and endocrine therapy resistance in breast cancer
- (2019) Phungern Khongthong et al. ENDOCRINE-RELATED CANCER
- Correlation Between the NLRP3 Inflammasome and the Prognosis of Patients With LSCC
- (2019) Yi Xue et al. Frontiers in Oncology
- The anticancer effect of the TLR4 inhibition using TAK‐242 (resatorvid) either as a single agent or in combination with chemotherapy: A novel therapeutic potential for breast cancer
- (2019) Zahra Zandi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- NLRP3 inflammasome activation by estrogen promotes the progression of human endometrial cancer
- (2019) Shuang-Ge Liu et al. OncoTargets and Therapy
- The association of aberrant expression of NLRP3 and p-S6K1 in colorectal cancer
- (2019) Bin Wang et al. PATHOLOGY RESEARCH AND PRACTICE
- NLRP3 inflammasome in fibroblasts links tissue damage with inflammation in breast cancer progression and metastasis
- (2019) Nour Ershaid et al. Nature Communications
- Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
- (2018) Rochanawan Sootichote et al. BMC CANCER
- NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway
- (2018) Xiao-Feng Yin et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma
- (2018) Concetta Saponaro et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3
- (2018) Hao Hu et al. Molecular Cancer
- P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer
- (2018) Hana Jin et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells
- (2018) Kunlin Wu et al. Molecular Medicine Reports
- Regulation of NLRP3 Inflammasome by Phosphorylation
- (2018) Nan Song et al. Frontiers in Immunology
- The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma
- (2017) Xiaodong Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma
- (2017) Cong-Fa Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The nuclear factor-kappa B pathway and response to treatment in breast cancer
- (2017) Yeon Hee Park PHARMACOGENOMICS
- Expression and clinical significance of SATB1 and TLR4 in breast cancer
- (2017) Xuebo Wang et al. Oncology Letters
- NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients
- (2017) Anita Mangia et al. Oncotarget
- Inflammasomes and Cancer
- (2017) Rajendra Karki et al. Cancer Immunology Research
- Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
- (2017) Melvin Kantono et al. Frontiers in Immunology
- Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells
- (2016) Hong Wang et al. EXPERIMENTAL CELL RESEARCH
- Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
- (2016) YAO YUAN et al. ONCOLOGY REPORTS
- Mechanisms and Functions of Inflammasomes
- (2014) Mohamed Lamkanfi et al. CELL
- TLRs: Linking inflammation and breast cancer
- (2014) Khyati Bhatelia et al. CELLULAR SIGNALLING
- Prognostic Value of Myeloid Differentiation Primary Response 88 and Toll-Like Receptor 4 in Breast Cancer Patients
- (2014) Fang-Jing Ma et al. PLoS One
- Significant correlation of TLR4 expression with the clinicopathological features of invasive ductal carcinoma of the breast
- (2013) Naureen Ehsan et al. TUMOR BIOLOGY
- Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis
- (2010) Salomé González-Reyes et al. BMC CANCER
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started